Inventor
KONETZKI INGO
DE50 patents
⚠️ This page may combine multiple inventors who share the name “KONETZKI INGO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BOEHRINGER INGELHEIM INT
20 patentsUS7491719B2Feb 17, 2009
Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments
BOEHRINGER INGELHEIM INT13 citations92
US7375104B2May 20, 2008
Long acting beta-2-agonists and their use as medicaments
BOEHRINGER INGELHEIM INT14 citations92
US7244728B2Jul 17, 2007
Long acting betamimetics for the treatment of respiratory diseases
BOEHRINGER INGELHEIM INT23 citations92
US7220742B2May 22, 2007
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
BOEHRINGER INGELHEIM INT32 citations92
US7160882B2Jan 9, 2007
Long acting β-2-agonists and their use as medicaments
BOEHRINGER INGELHEIM INT27 citations92
US7429583B2Sep 30, 2008
Betamimetics for the treatment of respiratory complaints
BOEHRINGER INGELHEIM INT12 citations84
US7423036B2Sep 9, 2008
Long-acting betamimetics for the treatment of respiratory complaints
BOEHRINGER INGELHEIM INT11 citations84
US7332175B2Feb 19, 2008
Long-acting drug combinations for the treatment of respiratory complaints
BOEHRINGER INGELHEIM INT14 citations84
US7307076B2Dec 11, 2007
Beta agonists for the treatment of respiratory diseases
BOEHRINGER INGELHEIM INT16 citations84
US7151114B2Dec 19, 2006
Use of substituted 2-phenylbenzimidazoles as medicaments
BOEHRINGER INGELHEIM INT17 citations84
US8372838B2Feb 12, 2013
Compounds as bradykinin B1 antagonists
BOEHRINGER INGELHEIM INT6 citations73
US8034809B2Oct 11, 2011
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
BOEHRINGER INGELHEIM INT2 citations63
US7709474B2May 4, 2010
Enantiomerically pure beta agonists, manufacturing and use thereof
BOEHRINGER INGELHEIM INT3 citations63
US7632834B2Dec 15, 2009
Long acting beta-2-agonists and their use as medicaments
BOEHRINGER INGELHEIM INT2 citations63
US7858618B2Dec 28, 2010
Compounds
BOEHRINGER INGELHEIM INT1 citations52
US7423035B2Sep 9, 2008
Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
BOEHRINGER INGELHEIM INT0 citations52
US7511067B2Mar 31, 2009
3-hydroxymethyl-4-hydroxy-phenyl-derivatives for the treatment of respiratory diseases
BOEHRINGER INGELHEIM INT0 citations51
US7563806B2Jul 21, 2009
Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
BOEHRINGER INGELHEIM INT0 citations49
US7405232B2Jul 29, 2008
Long acting beta-2 agonists and their use as medicaments
BOEHRINGER INGELHEIM INT0 citations42
US7754756B2Jul 13, 2010
Indol-containing beta-agonists, methods for the preparation thereof and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM INT0 citations38
GRUENENTHAL GMBH
16 patentsUS9546158B2Jan 17, 2017
2,5-substituted pyrimidines
GRUENENTHAL GMBH2 citations71
US9540349B2Jan 10, 2017
Substituted pyrimidine compounds
GRUENENTHAL GMBH2 citations71
US10981918B2Apr 20, 2021
Further substituted triazolo quinoxaline derivatives
GRUENENTHAL GMBH4 citations70
US10829480B2Nov 10, 2020
3-((hetero-)aryl)-alkyl-8-amino-2-oxo-l,3-diaza-spiro-[4.5]-decane derivatives
GRUENENTHAL GMBH1 citations61
US11981677B2May 14, 2024
Further substituted triazolo quinoxaline derivatives
GRUENENTHAL GMBH0 citations60
US10807988B2Oct 20, 2020
3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives
GRUENENTHAL GMBH1 citations60
US10391099B2Aug 27, 2019
Method of treating psoriatic arthritis, psoriasis, and chronic obstructive pulmonary disease with a novel 2,5-substituted pyrimidines
GRUENENTHAL GMBH0 citations51
US12110293B2Oct 8, 2024
Substituted triazolo quinoxaline derivatives
GRUENENTHAL GMBH0 citations49
US10189854B2Jan 29, 2019
Substituted pyrimidine compounds
GRUENENTHAL GMBH0 citations48
US9315490B2Apr 19, 2016
2,5-substituted pyrimidines
GRUENENTHAL GMBH2 citations48
US11999699B2Jun 4, 2024
Substituted pyrazole amides
GRUENENTHAL GMBH0 citations43
US10738015B2Aug 11, 2020
1,3-diaza-spiro-[3.4]-octane derivatives
GRUENENTHAL GMBH0 citations40
US9688683B2Jun 27, 2017
Substituted condensed pyrimidine compounds
GRUENENTHAL GMBH0 citations40
US9527832B2Dec 27, 2016
Substituted condensed pyrimidine compounds
GRUENENTHAL GMBH0 citations40
US9505724B2Nov 29, 2016
4-amino substituted condensed pyrimidine compounds as PDE4 inhibitors
GRUENENTHAL GMBH0 citations40
US9670189B2Jun 6, 2017
Substituted condensed pyrimidine compounds
GRUENENTHAL GMBH0 citations36
BOEHRINGER INGELHEIM PHARMA
8 patentsUS7056916B2Jun 6, 2006
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA43 citations96
US7417051B2Aug 26, 2008
Medicaments comprising betamimetics and a novel anticholinergic
BOEHRINGER INGELHEIM PHARMA38 citations92
US6951888B2Oct 4, 2005
Betamimetics with a prolonged duration of activity, processes for preparing them, and their use as pharmaceutical compositions
BOEHRINGER INGELHEIM PHARMA22 citations92
US7727984B2Jun 1, 2010
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA9 citations84
US7135500B2Nov 14, 2006
Dihydroxymethylphenyl derivatives, processes for preparing them, and their use as pharmaceuticals
BOEHRINGER INGELHEIM PHARMA16 citations83
US7786111B2Aug 31, 2010
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA5 citations73
US7250426B2Jul 31, 2007
Tiotropium-containing pharmaceutical combination for inhalation
BOEHRINGER INGELHEIM PHARMA7 citations71
US8044046B2Oct 25, 2011
Medicaments for the treatment of chronic obstructive pulmonary disease
BOEHRINGER INGELHEIM PHARMA2 citations62